Evidence map›Paper›PMID 36248010›Full record

ArticleDystonia (Lausanne, Switzerland)2022

Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.

Laura M Scorr, Hyun Joo Cho, Gamze Kilic-Berkmen, J Lucas McKay, Mark Hallett, Christine Klein, Tobias Baumer, Brian D Berman, Jeanne S Feuerstein, Joel S Perlmutter and 19 more

Open access · diamondAbstract read
In one paragraph

Article in Dystonia (Lausanne, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.Movement disorders : official journal of the Movement Disorder Society · 2024
    Trial
  3. Article
  4. Neuropathic Corneal Pain and Blepharospasm: A Case Series.Diagnostics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Meige syndrome with dyspnea as main manifestation: a report of one case and literature review].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Lesion-Induced Blepharospasm: Epidemiology and Clinical Characteristics.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025
    Article
  15. Article
  16. Article
  17. Oromandibular dystonia: from onset to spread a multicenter italian study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  18. Article
  19. Dystonia (Lausanne, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 4 countries.

Laura M ScorrDepartment of Neurology, School of Medicine, Emory University, Atlanta, GA, United States.
Hyun Joo ChoHuman Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Gamze Kilic-BerkmenDepartment of Neurology, School of Medicine, Emory University, Atlanta, GA, United States.
J Lucas McKayDepartment of Neurology, School of Medicine, Emory University, Atlanta, GA, United States.
Mark HallettHuman Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Christine KleinInstitute of Neurogenetics and Department of Neurology, University of Luebeck and University Hospital of Schleswig-Holstein, Luebeck, Germany.
Tobias BaumerInstitute of Neurogenetics and Department of Neurology, University of Luebeck and University Hospital of Schleswig-Holstein, Luebeck, Germany.
Brian D BermanDepartment of Neurology, Virginia Commonwealth University, Richmond, VA, United States.
Jeanne S FeuersteinDepartment of Neurology, University of Colorado, Aurora, CO, United States.
Joel S PerlmutterDepartment of Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy, Washington University School of Medicine, St Louis, MO, United States.
Alfredo BerardelliDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Gina FerrazzanoDepartment of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Aparna Wagle-ShuklaFixel Institute for Neurological Disease, Department of Neurology, University of Florida, Gainesville, FL, United States.
Irene A MalatyFixel Institute for Neurological Disease, Department of Neurology, University of Florida, Gainesville, FL, United States.
Joseph JankovicParkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, United States.
Steven T BellowsParkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, United States.
Richard L BarbanoDepartment of Neurology, University of Rochester, Rochester, NY, United States.
Marie VidailhetParis Brain Institute, Inserm, CNRS, AP-HP, Salpetrière Hospital, Sorbonne University, Paris, France.
Emmanuel RozeParis Brain Institute, Inserm, CNRS, AP-HP, Salpetrière Hospital, Sorbonne University, Paris, France.
Cecilia BonnetParis Brain Institute, Inserm, CNRS, AP-HP, Salpetrière Hospital, Sorbonne University, Paris, France.
Abhimanyu MahajanRush Parkinson's Disease and Movement Disorders Program, Department of Neurological Sciences, Rush University, Chicago, IL, United States.
Mark S LeDouxDepartment of Psychology, Veracity Neuroscience LLC, University of Memphis, Memphis, TN, United States.
Victor S C FungMovement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Florence C F ChangMovement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Giovanni DefazioDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Tomaso ErcoliDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Stewart FactorDepartment of Neurology, School of Medicine, Emory University, Atlanta, GA, United States.
Ted WojnoEmory Eye Center, Emory University, Atlanta, GA, United States.
H A JinnahDepartment of Neurology, School of Medicine, Emory University, Atlanta, GA, United States.
Emory University · USBaylor College of Medicine · USNational Institute of Neurological Disorders and Stroke · USSapienza University of Rome · ITThe University of Sydney · AUUniversity of Cagliari · ITDivision of Chemistry · USImmungenetics (Germany) · DEUniversity of Colorado Anschutz Medical Campus · USUniversity of Lübeck · DEUniversity of Rochester · USVirginia Commonwealth University · US

Funding

Medicinal Chemistry CoreU19NS110456 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI CHESTER A MATHIS · 2019 to 2026
$44.1M
INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASER01NS075321 · NINDS · WASHINGTON UNIVERSITY · PI CAMPBELL, MEGHAN C, PERLMUTTER, JOEL SYNES · 2011 to 2021
$8.2M
Dystonia Coalition- Pilot ProjectU54NS116025 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2019 to 2023
$7.1M
Dystonia CoalitionU54NS065701 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2009 to 2014
$7.0M
Protein Aggregation and Neurotransmitter Deficits in Parkinson DiseaseR01NS097799 · NINDS · WASHINGTON UNIVERSITY · PI PAUL T KOTZBAUER · 2016 to 2026
$5.8M
PET PROBES FOR IMAGING THE VESICULAR ACETYLCHOLINE TRANSPORTERR01NS075527 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2021
$4.9M
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological CorrelatesR01NS097437 · NINDS · WASHINGTON UNIVERSITY · PI MEGHAN C CAMPBELL · 2017 to 2026
$4.1M
Development and Translation of a PET Tracer for Specific and Early Detection of Alzheimer's DiseaseRF1AG064937 · NIA · WASHINGTON UNIVERSITY · PI BENZINGER, TAMMIE LEE SMITH, SHARMA, VIJAY · 2019 to 2019
$3.8M
Neuroinflammatory Biomarkers for Nigrostriatal InjuryR01NS107281 · NINDS · WASHINGTON UNIVERSITY · PI PERLMUTTER, JOEL SYNES · 2019 to 2023
$3.3M
NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITYR01ES029524 · NIEHS · WASHINGTON UNIVERSITY · PI CRISWELL, SUSAN · 2019 to 2023
$3.3M
Multi-tissue High-throughput Proteomic and Genomic Study in Parkinson's DiseaseR01NS118146 · NINDS · WASHINGTON UNIVERSITY · PI BENITEZ, BRUNO · 2020 to 2025
$3.2M
Neuroimaging of PDE10AR01NS103957 · NINDS · WASHINGTON UNIVERSITY · PI PERLMUTTER, JOEL SYNES, TU, ZHUDE · 2017 to 2021
$3.1M
NCATS NIH HHS U54 TR001456NCCIH NIH HHS R61 AT010753NIA NIH HHS R01 AG050263NIA NIH HHS R01 AG065214NIA NIH HHS RF1 AG064937NIEHS NIH HHS R01 ES029524NINDS NIH HHS K23 NS092957NINDS NIH HHS R01 NS075321NINDS NIH HHS R01 NS075527NINDS NIH HHS R01 NS092865NINDS NIH HHS R01 NS097437NINDS NIH HHS R01 NS097799NINDS NIH HHS R01 NS103957NINDS NIH HHS R01 NS107281NINDS NIH HHS R01 NS109487NINDS NIH HHS R01 NS118146NINDS NIH HHS R01 NS119831NINDS NIH HHS R01 NS121120NINDS NIH HHS RF1 NS075321NINDS NIH HHS U10 NS077366NINDS NIH HHS U10 NS077384NINDS NIH HHS U19 NS110456NINDS NIH HHS U54 NS065701NINDS NIH HHS U54 NS116025
6 · The paper itself

Abstract

Objective: Blepharospasm is a type of dystonia where the diagnosis is often delayed because its varied clinical manifestations are not well recognized. The purpose of this study was to provide a comprehensive picture of its clinical features including presenting features, motor features, and non-motor features. Methods: This was a two-part study. The first part involved a systematic literature review that summarized clinical features for 10,324 cases taken from 41 prior reports. The second part involved a summary of clinical features for 884 cases enrolled in a large multicenter cohort collected by the Dystonia Coalition investigators, along with an analysis of the factors that contribute to the spread of dystonia beyond the periocular region. Results: For cases in the literature and the Dystonia Coalition, blepharospasm emerged in the 50s and was more frequent in women. Many presented with non-specific motor symptoms such as increased blinking (51.9%) or non-motor sensory features such as eye soreness or pain (38.7%), photophobia (35.5%), or dry eyes (10.7%). Non-motor psychiatric features were also common including anxiety disorders (34-40%) and depression (21-24%). Among cases presenting with blepharospasm in the Dystonia Coalition cohort, 61% experienced spread of dystonia to other regions, most commonly the oromandibular region and neck. Features associated with spread included severity of blepharospasm, family history of dystonia, depression, and anxiety. Conclusions: This study provides a comprehensive summary of motor and non-motor features of blepharospasm, along with novel insights into factors that may be responsible for its poor diagnostic recognition and natural history.

Indexed as

BlepharospasmDystoniaeyesjawMeige syndromeOromandibular dystoniaphenotype

Identifiers

PMID36248010
PMCPMC9557246
OpenAlexW4280636379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.